NanoVibronix, Inc. (NASDAQ:NAOV) Short Interest Up 937.7% in December

NanoVibronix, Inc. (NASDAQ:NAOV) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 594,600 shares, a growth of 937.7% from the November 30th total of 57,300 shares. Based on an average daily volume of 384,900 shares, the short-interest ratio is currently 1.5 days. Currently, 15.9% of the shares of the stock are short sold.

NanoVibronix Trading Up 9.2 %

NAOV stock traded up $0.05 during mid-day trading on Thursday, hitting $0.58. The stock had a trading volume of 32,146 shares, compared to its average volume of 144,899. The firm has a fifty day simple moving average of $0.63 and a 200 day simple moving average of $0.65. The firm has a market capitalization of $2.19 million, a P/E ratio of -0.48 and a beta of 1.61. NanoVibronix has a 52 week low of $0.46 and a 52 week high of $1.52.

About NanoVibronix

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.